Brief: Bicycle Therapeutics Announces Bt5528 Phase I Dose Escalation Results In Patients With Advanced Solid Tumors
07/09/2022 12:23
Sept 7 (Reuters) - Bicycle Therapeutics PLC BCYC.O :
* BICYCLE THERAPEUTICS ANNOUNCES BT5528 PHASE I DOSE
ESCALATION
RESULTS IN PATIENTS WITH ADVANCED SOLID TUMORS
Source text for Eikon: ID:nBwbBL5rTa
Further company coverage: BCYC.O
(Reporting by Pratik Jain)
((Pratik.Jain@thomsonreuters.com;))
Recent news on Bicycle Therapeutics
See all newsBicycle Therapeutics PLC reports results for the quarter ended September 30 - Earnings Summary
UK's Bicycle Therapeutics Q3 loss narrows as expenses fall
Bicycle Therapeutics PLC expected to post a loss of 43 cents a share - Earnings Preview
UK's Bicycle Therapeutics Q2 net loss narrows on reduced clinical program expenses
Bicycle Therapeutics Q1 revenue drops after partnership terminations